HSHHSH Health Technology Supplier Hub
Home › Suppliers › Atos

Atos

HQ France · Europe

Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.

At a glance

Financial health
Band: Weak
Customer rating
No reviews yet

Financial health

Band: WeakListed: ATO.PA

FY2025 revenue €8.00bn (-16.4%); operating margin -10.3%; net loss €1.40bn.

Before restructuring and impairments its operating-margin KPI was €351m (4.4%); net debt €1.84bn.

Source: official results release · Year ended 2025-12-31 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.

YearRevenueGrowthOperating profitNet incomeCovers
FY2025€8bn-16.4%-€828m-€1.4bnAtos

Products & services

Products not yet catalogued.

Financial

FY2025 revenue €8.00bn (-16.4%); operating margin -10.3%; net loss €1.40bn.

Before restructuring and impairments its operating-margin KPI was €351m (4.4%); net debt €1.84bn.

Researched 8 Nov 2026

Adverse media

Apr 2026: first-quarter organic revenue fell 11% and Atos cut its 2026 outlook to a 1-5% decline; it emerged from a financial restructuring in 2024. Jan 2025: Atos denied a ransomware group's claim to have breached it.

Researched 8 Nov 2026

Cyber & information governance

Jan 2025: the Space Bears ransomware group claimed a breach; Atos said its own infrastructure was not compromised. No other incidents found in the last 24 months. NHS DSPT status not yet checked.

Researched 8 Nov 2026

Regulatory & clinical safety

Not yet researched.

Contract performance

Oct 2026: won a six-year application management contract worth up to £350m with the Metropolitan Police. No contract terminations found in HSH's search; Reuters notes earlier contract losses linked to the 2024 restructuring.

Researched 8 Nov 2026

Competitors

No competitors linked yet.

Customer reviews

No reviews yet